» Articles » PMID: 30808868

The Role of Cement Augmentation with Percutaneous Vertebroplasty and Balloon Kyphoplasty for the Treatment of Vertebral Compression Fractures in Multiple Myeloma: a Consensus Statement from the International Myeloma Working Group (IMWG)

Abstract

Multiple myeloma (MM) represents approximately 15% of haematological malignancies and most of the patients present with bone involvement. Focal or diffuse spinal osteolysis may result in significant morbidity by causing painful progressive vertebral compression fractures (VCFs) and deformities. Advances in the systemic treatment of myeloma have achieved high response rates and prolonged the survival significantly. Early diagnosis and management of skeletal events contribute to improving the prognosis and quality of life of MM patients. The management of patients with significant pain due to VCFs in the acute phase is not standardised. While some patients are successfully treated conservatively, and pain relief is achieved within a few weeks, a large percentage has disabling pain and morbidity and hence they are considered for surgical intervention. Balloon kyphoplasty and percutaneous vertebroplasty are minimally invasive procedures which have been shown to relieve pain and restore function. Despite increasing positive evidence for the use of these procedures, the indications, timing, efficacy, safety and their role in the treatment algorithm of myeloma spinal disease are yet to be elucidated. This paper reports an update of the consensus statement from the International Myeloma Working Group on the role of cement augmentation in myeloma patients with VCFs.

Citing Articles

Percutaneous vertebroplasty by two-step fluoroscopy: a treatment for osteoporotic compression fractures of thoracic vertebrae in older adults.

Ge J, Chen K, Xu P, Zhang Z, Wang K, Zhang T BMC Musculoskelet Disord. 2025; 26(1):135.

PMID: 39930416 PMC: 11809072. DOI: 10.1186/s12891-025-08403-7.


The Role of Transarterial Embolization Plus Radiotherapy Compared to Radiotherapy or Transarterial Embolization Alone in the Management of Painful Bone Metastases: Results of a Systematic Review.

Vizzuso A, Renzulli M, Lancellotta V, Posa A, Cornacchione P, Fionda B Cancers (Basel). 2025; 16(24.

PMID: 39766082 PMC: 11674161. DOI: 10.3390/cancers16244183.


Enhancing prognosis in multiple myeloma bone disease: insights from a retrospective analysis of surgical interventions.

Shi X, Yao X, Wu Y, Du B, Du X Front Surg. 2025; 11:1433265.

PMID: 39749125 PMC: 11693696. DOI: 10.3389/fsurg.2024.1433265.


Proximal femoral multiple myeloma pathological fractures, impending and actual fractures - a patient survival study.

Hershkovich O, Sakhnini M, Barkay G, Liberman B, Friedlander A, Lotan R BMC Cancer. 2024; 24(1):917.

PMID: 39080587 PMC: 11290202. DOI: 10.1186/s12885-024-12681-0.


Percutaneous vertebroplasty/kyphoplasty contributes to the improved outcome in patients with newly diagnosed multiple myeloma: A single center cohort study.

Zhang F, Liu S, Zhou X, Wang W, Jia C, Wang Q J Bone Oncol. 2024; 47:100615.

PMID: 39036812 PMC: 11259919. DOI: 10.1016/j.jbo.2024.100615.


References
1.
Butler J, Malhotra K, Patel A, Sewell M, Benton A, Kyriakou C . Pathologic sternal involvement is a potential risk factor for severe sagittal plane deformity in multiple myeloma with concomitant thoracic fractures. Spine J. 2015; 15(12):2503-8. DOI: 10.1016/j.spinee.2015.09.031. View

2.
Malhotra K, Butler J, Yu H, Selvadurai S, DSa S, Rabin N . Spinal disease in myeloma: cohort analysis at a specialist spinal surgery centre indicates benefit of early surgical augmentation or bracing. BMC Cancer. 2016; 16:444. PMC: 4939590. DOI: 10.1186/s12885-016-2495-7. View

3.
Fisher C, DiPaola C, Ryken T, Bilsky M, Shaffrey C, Berven S . A novel classification system for spinal instability in neoplastic disease: an evidence-based approach and expert consensus from the Spine Oncology Study Group. Spine (Phila Pa 1976). 2010; 35(22):E1221-9. DOI: 10.1097/BRS.0b013e3181e16ae2. View

4.
Landgren O, Rajkumar S . New Developments in Diagnosis, Prognosis, and Assessment of Response in Multiple Myeloma. Clin Cancer Res. 2017; 22(22):5428-5433. PMC: 5587183. DOI: 10.1158/1078-0432.CCR-16-0866. View

5.
Terpos E, Ntanasis-Stathopoulos I, Gavriatopoulou M, Dimopoulos M . Pathogenesis of bone disease in multiple myeloma: from bench to bedside. Blood Cancer J. 2018; 8(1):7. PMC: 5802524. DOI: 10.1038/s41408-017-0037-4. View